Business · 19/11/2014Updated: 10/17/2026 · 1 min read
FDA Opens Public Docket for Proposed Criteria on 'First Generic' ANDA Submissions
Summary
The FDA is seeking public comments on proposed criteria for prioritizing 'first generic' abbreviated new drug application (ANDA) submissions, aiming to improve review prioritization under the Generic Drug User Fee Amendments of 2012 (GDUFA)